Deep Analysis of Impact of COVID-19 on “Blood Gas and Electrolyte Analyzers Market 2012-2022” Growth Worldwide….
Global blood gas
and electrolyte market is
expected to reach USD 653.5 million by
2022, according to a new study by Grand View Research Inc. Rising number of
patients in ICU and critical care units and increasing demand for high
throughput and integrated systems are some key factors likely to drive the
blood gas and electrolyte analyzers market. Growing global geriatric population
base is also expected to significantly contribute towards market growth over
the forecast period, by triggering the incidence rates of target diseases and
widening the base of patients requiring critical care. Furthermore, the
emergence of multi-parameter monitoring devices owing to, expanding test menus
and growing demand for portable devices is expected to boost usage rates over
the forecast period. The availability of blood gas analyzers has helped enhance
the care of critically ill patients allowing for frequent diagnosis and
monitoring of respiratory problems and ability to guide prognosis and therapy.
Rising demand for technically advanced sleek handheld devices involving short
turnaround time has resulted in the development of more compact, sleek,
handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and
electrolyte analyzers use innovative optical technology and provide fast
results while requiring minimal maintenance.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
The global blood gas and electrolyte analyzers market size is
anticipated to reach USD 653.5 million by 2022. Factors that are driving the
growth include increase in number of patients in intensive care units,
emergency departments, and operation rooms, rising demand for high throughput
and integrated systems, consolidation of diagnostic facilities, awareness about
accreditation, and increasing affordability of patients.
To Request Sample Copy of this report, click the link:
Key players for
this market include Siemens, Medica, Roche, Erba, Nova stat, Bayer, Radiometer
Medical, Samsung Medison, Edan Instruments, OPTI Medical systems Inc.,
Convergent Technologies, Alere Medical, Accurex, and Dalko Diagnostics.
Further key findings from the study suggest:
·
Portable analyzers dominated the market
with a share of over 60.0% in 2014 and are also expected to witness lucrative
growth over the forecast period. Growing demand for automated, self-monitoring,
portable devices, shorter analysis time, and quick accurate results are key
factors boosting the growth of this segment.
·
Combined blood gas and electrolyte
analyzers are expected to rapidly gain market share over the forecast period.
Rising need for analyzers, which can analyze blood and electrolyte samples
together are swiftly gaining popularity among users.
·
North America accounted for more than 40%
of the blood gas and electrolyte analyzers market in 2014. Presence of
sophisticated healthcare infrastructure along with favorable reimbursement
plans are some key factors expected to drive regional market growth.
·
Presence of high unmet needs clubbed with
rapidly improving healthcare infrastructure in the emerging markets of India
and China is expected to help Asia Pacific grow at a lucrative rate throughout
the forecast period. Growing demand for decentralized point-of-care diagnostic
facilities handling large volumes of diagnostic tests is also expected to drive
regional market growth.
·
Key players of the blood gas and
electrolyte analyzers market include Siemens, Medica, Roche, Nova Stat, Bayer,
Radiometer Medical, Convergent technologies, Dalko Diagnostics, Afford Medical
Technologies, and Accurex Biomedical Pvt. Ltd.
In
recent years, the geriatric population has been on a rise which has led to an
increase in the number of patients in emergency departments, critical care
units, and operating rooms receiving critical care. This in turn fuels the
market potential for blood gas and electrolyte analyzers. According to WHO the
global population of age group 65 years and above is estimated to increase from
7% in 2000 to 16% in 2050. Aging is considered as one of the greatest risk
factors for the development of cancer and therefore, the fact that the
geriatric population is expected to grow over the next six years is one of the
factors that will drive the growth.
Portable
blood gas and electrolyte analyzers market is marked by continuous innovations
and technology improvements which are amongst key factors attributing to the
growth of the market. Innovation and technological advancements has resulted in
the development of novel devices from bench-top to more compact, handheld, and
sleek point-of-care devices. Point-of-care devices offer rapid analysis at the
point of need due to its ease-of-use, accuracy, short turnaround time, and
portability.
The
need for expanded test menus is additionally integrating the functionalities of
both blood gas and electrolyte analysis to offer multiple testing of
electrolytes, bilirubin, creatinine, and blood urea nitrogen from a single
sample. For instance, Sphere medical Ltd, located in Cambridge, UK designed a
blood chemical analyzer which includes a disposable sensor and an application
specific integrated circuit (ASIC). The device can measure single or some
multiple components in a given blood sample simultaneously.
Browse Press
Release of this report:
Grand View Research has segmented the blood
gas and electrolyte analyzers market on the basis of products, application,
end-use:
Global Blood Gas and Electrolyte Analyzers Market,
Product Outlook (Revenue, USD Million, 2012 - 2022)
·
Benchtop
·
Portable
Global Blood Gas and Electrolyte Analyzers Market,
Application Outlook (Revenue, USD Million, 2012 - 2022)
·
Blood gas analyzers
·
Electrolyte analyzers
·
Combined analyzers
Global Blood Gas and Electrolyte Analyzers Market,
End-use Outlook (Revenue, USD Million, 2012 - 2022)
·
Clinical laboratories
·
Point-of-care
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.

Comments
Post a Comment